307 related articles for article (PubMed ID: 32035678)
1. Direct-Acting Antiretroviral Therapy in Renal Transplant Recipients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Report of Our Experience and Literature Review.
Moreno-Ramirez M; Villanego F; Vigara LA; Cazorla JM; Naranjo J; Garcia T; Merino MJ; Mazuecos A
Transplant Proc; 2020 Mar; 52(2):523-526. PubMed ID: 32035678
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
[TBL] [Abstract][Full Text] [Related]
3. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
4. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.
Corma-Gómez A; Morano L; Téllez F; Rivero-Juárez A; Real LM; Alados JC; Ríos-Villegas MJ; Vera-Méndez FJ; Muñoz RP; Geijo P; Macías J; Pineda JA;
AIDS; 2019 Jun; 33(7):1167-1174. PubMed ID: 30845068
[TBL] [Abstract][Full Text] [Related]
5. Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.
Gayam V; Hossain MR; Khalid M; Chakaraborty S; Mukhtar O; Dahal S; Mandal AK; Gill A; Garlapati P; Ramakrishnaiah S; Mowyad K; Sherigar J; Mansour M; Mohanty S
Gut Liver; 2018 Nov; 12(6):694-703. PubMed ID: 29938459
[TBL] [Abstract][Full Text] [Related]
6. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
Manzardo C; Londoño MC; Castells L; Testillano M; Luis Montero J; Peñafiel J; Subirana M; Moreno A; Aguilera V; Luisa González-Diéguez M; Calvo-Pulido J; Xiol X; Salcedo M; Cuervas-Mons V; Manuel Sousa J; Suarez F; Serrano T; Ignacio Herrero J; Jiménez M; Fernandez JR; Giménez C; Del Campo S; Esteban-Mur JI; Crespo G; Moreno A; de la Rosa G; Rimola A; Miro JM;
Am J Transplant; 2018 Oct; 18(10):2513-2522. PubMed ID: 29963780
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Sofosbuvir and Ribavirin for Eradicating Hepatitis C Virus in Renal Transplant Recipients in Pakistan: Where Resources Are Scarce.
Hanif FM; Laeeq SM; Mandhwani RK; Luck NH; Aziz T; Mehdi SH
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):63-67. PubMed ID: 28260436
[TBL] [Abstract][Full Text] [Related]
8. Virological Response to Sofosbuvir-Based Treatment in Renal Transplant Recipients With Hepatitis C in Pakistan.
Hanif FM; Mandhwani R; Lail G; Luck NH; Aziz T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):198-201. PubMed ID: 30777554
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication.
Suarez Benjumea A; Gonzalez-Corvillo C; Sousa JM; Bernal Blanco G; Suñer Poblet M; Perez Valdivia MA; Gonzalez Roncero FM; Acevedo P; Gentil Govantez MA
Transplant Proc; 2016 Nov; 48(9):2938-2940. PubMed ID: 27932111
[TBL] [Abstract][Full Text] [Related]
10. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Xiao H; Chen J; Wang J; Li J; Yang F; Lu H
Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
Weigert A; Querido S; Carvalho L; Lebre L; Chagas C; Matias P; Birne R; Nascimento C; Jorge C; Adragão T; Bruges M; Machado D
Transplant Proc; 2018 Apr; 50(3):743-745. PubMed ID: 29661427
[TBL] [Abstract][Full Text] [Related]
12. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
Peters MG; Kottilil S; Terrault N; Amara D; Husson J; Huprikar S; Florman S; Sulkowski MS; Durand CM; Luetkemeyer AF; Rogers R; Grab J; Haydel B; Blumberg E; Dove L; Emond J; Olthoff K; Smith C; Fishbein T; Masur H; Stock PG
Am J Transplant; 2021 May; 21(5):1780-1788. PubMed ID: 33277801
[TBL] [Abstract][Full Text] [Related]
13. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
[TBL] [Abstract][Full Text] [Related]
14. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
Zeremski M; Martinez AD; Talal AH
Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
[No Abstract] [Full Text] [Related]
15. Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.
Grottenthaler JM; Werner CR; Steurer M; Spengler U; Berg T; Engelmann C; Wedemeyer H; von Hahn T; Stremmel W; Pathil A; Seybold U; Schott E; Blessin U; Sarrazin C; Welker MW; Harrer E; Scholten S; Hinterleitner C; Lauer UM; Malek NP; Berg CP
PLoS One; 2018; 13(6):e0197544. PubMed ID: 29874250
[TBL] [Abstract][Full Text] [Related]
16. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
Campos-Varela I; Moreno A; Morbey A; Guaraldi G; Hasson H; Bhamidimarri KR; Castells L; Grewal P; Baños I; Bellot P; Brainard DM; McHutchison JG; Terrault NA
Aliment Pharmacol Ther; 2016 Jun; 43(12):1319-29. PubMed ID: 27098374
[TBL] [Abstract][Full Text] [Related]
18. Concomitant Treatment of Hepatitis C Virus and Diffuse Large B-Cell Lymphoma with Direct-Acting Antivirals in HIV Coinfection: A Case Report.
Gallipani A; Cha A; Berkowitz L; Bakshi A
J Int Assoc Provid AIDS Care; 2019; 18():2325958218822062. PubMed ID: 30798652
[TBL] [Abstract][Full Text] [Related]
19. IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting.
Londoño MC; Manzardo C; Rimola A; Ruiz P; Costa J; Forner A; Ambrosioni J; Agüero F; Laguno M; Lligoña A; Moreno A; Miró JM
J Antimicrob Chemother; 2016 Nov; 71(11):3195-3201. PubMed ID: 27402009
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients.
D'Ambrosio R; Vinci M; Franchina M; Parlati L; Zaltron S; Pasulo L; Campise M; Messa P; Pol S; Lampertico P
Kidney Int; 2019 Apr; 95(4):993-995. PubMed ID: 30904073
[No Abstract] [Full Text] [Related]
[Next] [New Search]